ARCHIVES

Robert Cook-Deegan On Implications of Appelate Court Ruling In Myriad Case Ruling

This article is from The Cancer Letter archive.

Vol. 37 No. 31 | August 5, 2011

Download PDF Visit The Full Archive

Related Articles

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

Treatment IND or GM-CSF Is Approved

October 5, 1990

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

In Brief: James Cancer Hospial Recieves $20M Donation

January 22, 1999

NCI Splits Prevention and control Division; Rimer to Direct Division Of Cancer Conrol

July 25, 1997

Special Report on the American Legacy Foundation: As Legacy seeks new funding, critics fear symbiosis with Big Tobacco. Legacy, NCI, C-Change relationship could open door to industry influence, lawyer says.

October 29, 2004